Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Bir Dawn Carter Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2023 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Disposed/sold 33,805 shares @ $0
Disposed/sold 16,500 options to buy @ $121.29, valued at $2M
Disposed/sold 70,000 options to buy @ $27.32, valued at $1.9M
Disposed/sold 63,650 options to buy @ $36.71, valued at $2.3M
Disposed/sold 71,300 options to buy @ $24.75, valued at $1.8M
Disposed/sold 34,500 options to buy @ $55.73, valued at $1.9M
Disposed/sold 17,250 options to buy @ $55.73, valued at $961.3k
Disposed/sold 24,000 options to buy @ $207.2, valued at $5M
08/17/2023 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Sold 807 shares @ $169.0367, valued at $136.4k
Sold 398 shares @ $168.3317, valued at $67k
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2023 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Granted 4,125 shares @ $0
06/02/2023 4 Bir Dawn Carter (Director) has filed a Form 4 on GERON CORP
Txns: Granted 125,000 options to buy @ $3.27, valued at $408.8k
05/17/2023 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Sold 894 shares @ $85.09, valued at $76.1k
Sold 417 shares @ $80.955, valued at $33.8k
03/15/2023 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Sold 9,317 shares @ $86.77, valued at $808.4k
03/08/2023 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Converted 48,370 shares @ $0
Sold 40,134 shares @ $89.3, valued at $3.6M
Sold 14,820 shares @ $90.26, valued at $1.3M
Converted 41,630 shares @ $0
Sold 36,049 shares @ $85.08, valued at $3.1M
Sold 5,793 shares @ $85.9, valued at $497.6k
Sold 200 shares @ $86.67, valued at $17.3k
Exercised 48,370 options to buy @ $21.05, valued at $1M
Converted 48,370 options to buy @ $0
Exercised 41,630 options to buy @ $21.05, valued at $876.3k
Converted 41,630 options to buy @ $0
03/06/2023 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Sold 2,166 shares @ $88.2491, valued at $191.1k
01/04/2023 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Granted 15,675 shares @ $0
Granted 63,650 options to buy @ $36.71, valued at $2.3M
05/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Granted 35,000 shares @ $0
Granted 70,000 options to buy @ $27.32, valued at $1.9M
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2020 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Converted 60,000 shares @ $0
Sold 30,000 shares @ $150.01, valued at $4.5M
Sold 30,000 shares @ $175, valued at $5.3M
Exercised 60,000 options to buy @ $21.05, valued at $1.3M
Converted 60,000 options to buy @ $0
06/09/2020 4 Bir Dawn Carter (Director) has filed a Form 4 on GERON CORP
Txns: Granted 83,000 options to buy @ $1.54, valued at $127.8k
01/06/2020 4 Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Granted 24,000 options to buy @ $207.2, valued at $5M
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2019 4 Bir Dawn Carter (Director) has filed a Form 4 on GERON CORP
Txns: Granted 70,000 options to buy @ $1.38, valued at $96.6k
03/28/2019 4 Bir Dawn Carter (Director) has filed a Form 4 on GERON CORP
Txns: Granted 120,000 options to buy @ $1.68, valued at $201.6k
01/03/2019 4 Bir Dawn Carter (VP, Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Granted 34,500 options to buy @ $55.73, valued at $1.9M
12/07/2017 4 Bir Dawn Carter (VP, Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC
Txns: Granted 71,300 options to buy @ $24.75, valued at $1.8M
12/08/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy